A global perspective on vaccine safety and public health: The global advisory committee on vaccine safety

被引:46
作者
Folb, PI
Bernatowska, E
Chen, R
Clemens, J
Dodoo, ANO
Ellenberg, SS
Farrington, P
John, TJ
Lambert, PH
MacDonald, NE
Miller, E
Salisbury, D
Schmitt, HJ
Siegrist, CA
Wimalaratne, O
机构
[1] MRC, ZA-7505 Cape Town, South Africa
[2] Childrens Mem Hlth Inst, Dept Immunol, Warsaw, Poland
[3] Ctr Dis Control & Prevent, Immunizat Safety Branch, Atlanta, GA USA
[4] Int Vaccine Inst, Seoul, South Korea
[5] Univ Ghana, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana
[6] US FDA, Off Biostat & Epidemiol, Rockville, MD 20857 USA
[7] Open Univ, Dept Stat, Milton Keynes MK7 6AA, Bucks, England
[8] Kerala State Inst Virol & Infect Dis, Vellore, Tamil Nadu, India
[9] Ctr Med Univ Geneva, Collaborating Ctr Neonatal Vaccinol, WHO, CH-1211 Geneva, Switzerland
[10] Dalhousie Univ, Dept Paediat, Halifax, NS, Canada
[11] Hlth Protect Agcy, Immunisat Dept, London, England
[12] Dept Hlth, Communicable Dis & Immunisat Team, London SE1 6TE, England
[13] Univ Mainz, Ctr Prevent Pediat, D-6500 Mainz, Germany
[14] Med Res Inst, Dept Rabies & Vaccines, Colombo, Sri Lanka
关键词
D O I
10.2105/AJPH.94.11.1926
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Established in 1999, the Global Advisory Committee on Vaccine Safety advises the World Health Organization (WHO) on vaccine-related safety issues and enables WHO to respond promptly, efficiently, and with scientific rigor to issues of vaccine safety with potential global importance. The committee also assesses the implications of vaccine safety for practice worldwide and for WHO policies. We describe the principles on which the committee was established-its modus operandi, and the scope of the work undertaken, both present and future. We highlight its recent recommendations on major issues, including the purported link between the measles-mumps-rubella vaccine and autism and the safety of the mumps, influenza, yellow fever, BCG, and smallpox vaccines as well as that of thiomersal-containing vaccines.
引用
收藏
页码:1926 / 1931
页数:6
相关论文
共 35 条
[1]   Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies [J].
Aaby, P ;
Jensen, H ;
Samb, B ;
Cisse, B ;
Sodemann, M ;
Jakobsen, M ;
Poulsen, A ;
Rodrigues, A ;
Lisse, IM ;
Simondon, F ;
Whittle, H .
LANCET, 2003, 361 (9376) :2183-2188
[2]  
[Anonymous], 2001, WKLY EPIDEMIOL REC, V76, P85
[3]  
[Anonymous], STAT WORLDS VACC IMM
[4]   First 5 years of measles elimination in southern Africa: 1996-2000 [J].
Biellik, R ;
Madema, S ;
Taole, A ;
Kutsulukuta, A ;
Allies, E ;
Eggers, R ;
Ngcobo, N ;
Nxumalo, M ;
Shearley, A ;
Mabuzane, E ;
Kufa, E ;
Okwo-Bele, JM .
LANCET, 2002, 359 (9317) :1564-1568
[5]   Hepatitis and death following vaccination with 17D-204 yellow fever vaccine [J].
Chan, RC ;
Penney, DJ ;
Little, D ;
Carter, IW ;
Roberts, JA ;
Rawlinson, WD .
LANCET, 2001, 358 (9276) :121-122
[6]   Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain [J].
da Cunha, SS ;
Rodrigues, LC ;
Barreto, ML ;
Dourado, I .
VACCINE, 2002, 20 (7-8) :1106-1112
[7]   Time trends in autism and in MMR immunization coverage in California [J].
Dales, L ;
Hammer, SJ ;
Smith, NJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (09) :1183-1185
[8]  
DeWilde S, 2001, BRIT J GEN PRACT, V51, P226
[9]  
Santos Boaventura Antônio dos, 2002, Rev Panam Salud Publica, V12, P240, DOI 10.1590/S1020-49892002001000004
[10]  
Dourado I, 2000, AM J EPIDEMIOL, V151, P524, DOI 10.1093/oxfordjournals.aje.a010239